Sunho Biologics, Inc. (HKG:2898)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.40
0.00 (0.00%)
Mar 6, 2026, 1:25 PM HKT

Sunho Biologics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.020.0417.531.853.22
Revenue Growth
-55.26%-99.78%847.78%-42.48%-
Gross Profit
0.020.0417.531.853.22
Operating Income
-89.84-101.36-66.28-58.14-66.62
Net Income
-82.09-79.97-132.7-51.99-70.63
Earnings Per Share
-0.54-0.62-1.43-0.57-0.78
EPS Growth
-----

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
409.55457.28210.071.8210.67
Total Debt
68.2441.29.0711.03160.86
Net Cash (Debt)
341.3416.09200.99-9.2-150.19
Net Cash Growth
-17.97%107.02%---
Net Cash Per Share
2.263.252.16-0.10-1.65

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-24.94-109.02-40.65-34.59-52.65
Capital Expenditures
-41.05-39.37-1.03-1.44-5.52
Free Cash Flow
-65.98-148.39-41.68-36.03-58.17
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-528488.23%-266723.68%-378.00%-3142.54%-2071.39%
Pretax Margin
-482864.71%-210434.21%-756.82%-2810.16%-2196.27%
Profit Margin
-482864.71%-210434.21%-756.82%-2810.16%-2196.27%
FCF Margin
-388135.29%-390505.26%-237.73%-1947.30%-1808.71%

Valuation

Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
52095.1714009.09---